Trial Profile
CINJ 090802: A Phase II Trial of Riluzole in Patients with Advanced Melanoma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Jan 2024
Price :
$35
*
At a glance
- Drugs Riluzole (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 01 Jul 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Nov 2012 Planned End Date changed from 1 Apr 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.
- 12 Oct 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.